Cite
MLA Citation
C. Di Raimondo et al.. “Rituximab, lenalidomide and pembrolizumab in refractory primary cutaneous diffuse large B cell lymphoma, leg type.” European journal of cancer, vol. 119, n.d., pp. S43–S44. http://access.bl.uk/ark:/81055/vdc_100093290012.0x00001e